'Impressive' Results for Intranasal Ketamine in Migraine

Intranasal ketamine may offer new hope for people with chronic, refractory migraines where other treatments fail. However, concerns about the addictive nature of the drug may limit its use.

Related Keywords

New York ,United States ,Jefferson Center ,Pennsylvania ,Philadelphia ,Thomas Jefferson University ,Richard Lipton ,Lipton ,Jefferson Headache Center ,Drug Administration ,Hsiangkuo Yuan ,Medscape Medical ,Jefferson Headache ,Regional Anesthesia ,Medscape Medical News ,Montefiore Headache Center ,Albert Einstein College ,New York City ,Migraine ,Migraine Headache ,Eadache Migraine ,Refractory ,Classical Migraine ,Common Migraine ,Chronic Pain ,Headache ,Spain ,Pain Management ,Hallucinogens ,Acute Pain ,Quality Of Life ,Pol ,Ealth Related Quality Of Life ,Rqol ,Adverse Effects ,Side Effects ,Anesthesia ,Anesthetic ,Clinical Research ,Clinical Trials ,Linical Studies ,Cluster Headach ,